Intuitive Surgical Inc (ISRG)
386.72
+1.27
(+0.33%)
USD |
NASDAQ |
May 10, 16:00
386.91
+0.19
(+0.05%)
After-Hours: 20:00
Intuitive Surgical Cash from Financing (TTM): 46.90M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 46.90M |
December 31, 2023 | -287.60M |
September 30, 2023 | -1.220B |
June 30, 2023 | -2.208B |
March 31, 2023 | -2.754B |
December 31, 2022 | -2.572B |
September 30, 2022 | -1.590B |
June 30, 2022 | -595.10M |
March 31, 2022 | -54.70M |
December 31, 2021 | 43.00M |
September 30, 2021 | -15.40M |
June 30, 2021 | 1.50M |
March 31, 2021 | -9.20M |
December 31, 2020 | -85.70M |
September 30, 2020 | 4.90M |
June 30, 2020 | -79.10M |
March 31, 2020 | -305.30M |
December 31, 2019 | -168.40M |
September 30, 2019 | -185.50M |
June 30, 2019 | -129.00M |
March 31, 2019 | 92.80M |
December 31, 2018 | 126.30M |
September 30, 2018 | -150.50M |
June 30, 2018 | -124.60M |
March 31, 2018 | -43.10M |
Date | Value |
---|---|
December 31, 2017 | -1.913B |
September 30, 2017 | -1.675B |
June 30, 2017 | -1.658B |
March 31, 2017 | -1.594B |
December 31, 2016 | 514.40M |
September 30, 2016 | 461.00M |
June 30, 2016 | 472.90M |
March 31, 2016 | 323.20M |
December 31, 2015 | 159.10M |
September 30, 2015 | 333.60M |
June 30, 2015 | 315.80M |
March 31, 2015 | -697.00M |
December 31, 2014 | -692.40M |
September 30, 2014 | -779.20M |
June 30, 2014 | -1.537B |
March 31, 2014 | -804.20M |
December 31, 2013 | -910.60M |
September 30, 2013 | -867.10M |
June 30, 2013 | -325.60M |
March 31, 2013 | -19.70M |
December 31, 2012 | 119.20M |
September 30, 2012 | 139.00M |
June 30, 2012 | 190.70M |
March 31, 2012 | 29.10M |
December 31, 2011 | -12.40M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.754B
Minimum
Mar 2023
46.90M
Maximum
Mar 2024
-608.13M
Average
-148.70M
Median
Cash from Financing (TTM) Benchmarks
Abbott Laboratories | -6.857B |
Boston Scientific Corp | 1.643B |
Becton Dickinson & Co | -1.949B |
Alphatec Holdings Inc | 285.44M |
Masimo Corp | -48.40M |